AVITA Medical, Inc (RCEL) insider trading

Every open-market stock purchase and sale by AVITA Medical, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $143K over the last 12 months (8 buys).
  • Last insider buy: Joseph Fralin Woody (Insider), $20.9K, 4 months ago.

Last 12 months: insiders bought $143K (8 buys) and sold $0 (0 sales). Last close $4.16 on Jun 7, 2026.

Recent RCEL insider trades

DateInsiderTradeValue
Jun 12, 2026David D O'Toole (CFO)Bought (not open market)$7.9K
Jun 9, 2026Joseph Fralin Woody (Insider)Bought$20.9K
Jun 9, 2026Joseph Fralin Woody (Insider)Bought$20.8K
Jun 3, 2026Joseph Fralin Woody (Insider)Bought$20.4K
Jun 2, 2026Joseph Fralin Woody (Insider)Bought$21K
Jun 1, 2026Joseph Fralin Woody (Insider)Bought$21.3K
May 29, 2026Cary Guy Vance (CEO)Bought (not open market)$15.3K
May 29, 2026David D O'Toole (CFO)Bought (not open market)$15.3K
May 20, 2026David D O'Toole (CFO)Bought$8.5K
May 19, 2026David D O'Toole (CFO)Bought$8.5K
Mar 11, 2026David D O'Toole (CFO)Bought$8.6K
Feb 19, 2026David D O'Toole (CFO)Bought$12.4K
Feb 18, 2026Nicole Kelsey (C-suite exec)Bought (not open market)—
Feb 18, 2026David D O'Toole (CFO)Bought (not open market)—
Feb 18, 2026Nicole Kelsey (C-suite exec)Bought (not open market)—
Feb 18, 2026David D O'Toole (CFO)Bought (not open market)—
Jan 20, 2026Robert McNamara (Insider)Bought (not open market)—
Jan 20, 2026Jeremy Curnock Cook (Insider)Bought (not open market)—
Jan 20, 2026Joseph Fralin Woody (Insider)Bought (not open market)—
Jan 20, 2026Suzanne Crowe (Insider)Bought (not open market)—
Jan 20, 2026Suzanne Crowe (Insider)Bought (not open market)—
Jan 20, 2026Jan Stern Reed (Insider)Bought (not open market)—
Jan 20, 2026Jan Stern Reed (Insider)Bought (not open market)—
Jan 20, 2026Jeremy Curnock Cook (Insider)Bought (not open market)—
Jan 20, 2026Robert McNamara (Insider)Bought (not open market)—

Who's trading RCEL

Get free alerts when an insider at AVITA Medical, Inc files a new trade →